Eyenovia inc.

Major-Pharmaceuticals

EYEN


295 Madison Avenue
New York , NY 10017

Executive/
Director

Price

  • Last Close
  • $ 0.11
    $ -0.01 -9.17 %
    Jan 3, 2025
  • 52-Week High/Low
  • $2.37 - $0.46
  • YTD
  • 0%

  • Trading Volume
  • 533,122
  • Market Cap Full
  • $ 4.9M
  • Shares Outstanding
  • 44.1M
    Nov 9, 2023
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Q1 - - 110.2% -5% -14.9% -23.8% 116.6% -52.8% -26.9% -
Q2 - -28.1% -30.2% 4% -3.9% -36.1% -32.9% -26.6% - -
Q3 - -36.2% -10.8% 8% -1.2% 0.3% -30% -59.4% - -
Q4 - -28.8% 15.2% 94.2% -18.4% -16.6% 33.3% 52% - -
J F M A M J J A S O N D
2026 - - - - - - - - - - - -
2025 -26.9% - - - - - - - - - - -
    2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
    0%0%0%54%38%-34%-59%28%-93%-27%0%

Earnings

2017 2018 2019 2020 2021 2022 2023
Q1 - -0.45 -0.5 -0.31 -0.21 -0.24 -0.15
Q2 - -0.33 -0.44 -0.25 -0.19 -0.22 -0.16
Q3 - -0.43 -0.29 -0.23 -0.21 -0.21 -0.18
Q4 0.84 -0.61 -0.24 -0.15 0.12 -0.16 -
A 0.8 -1.8 -1.5 -0.9 -0.5 -0.8 -0.49

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 12 19.8 25.6 31.7 38
Jun 9.9 12 19.8 25.9 33.6 38
Sep 10 17.1 20.5 25.9 34.2 -
Dec 10.1 17.1 24.9 28.4 36.1 44.1

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - 1.6 - - -
Total Asset Turnover - 0.4 0.1 - -
Leverage
Debt Ratio 0.1 - - - -
Debt – Equity Ratio 0.2 - - - -
Interest Coverage -27 - - - -
Equity multiplier 0.1 0.5 - - -